The activation of PKM2 in hypoxic BC cells leads to the activation of NF-κB/p65 and HIF-1α, resulting in increased production and secretion of vascular endothelial growth factor (VEGF), which promotes angiogenesis and tumor growth (41). Here, PKM is linked to breast cancer.